| St. Louis, MO -- May 02, 2007 -- /prbuzz/ -- Interstitial Lung Disease evaluation MedicalTemplate launched MedicalTemplates have expanded to include an Interstitial Lung Disease evaluation. This evaluation is a physician designed Adobe PDF medical note template. This MedicalTemplate has editable text fields and working checkboxes to easily assist in rapid and thorough medical documentation during the evaluation of patients with known or possible interstitial lung disease. Interstitial Lung Disease (ILD) is a diverse group of more than 200 diseases that cause progressive fibrosis (scarring) of lung tissue, which leads to chronic, progressive breathlessness and respiratory failure. The Pulmonary Fibrosis Foundation (www.pulmonaryfibrosis.org) estimates that more than 200,000 Americans have ILD, and nearly 40,000 Americans die each year from ILD. ILD includes idiopathic pulmonary fibrosis (IPF), sarcoidosis, hypersensitivity pneumonitis, Nonspecific Interstitial Pneumonitis (NSIP), Desquamative Interstitial Pneumonitis (DIP), Cryptogenic Organizing Pneumonia (COP, also known as BOOP), medication induced lung disease, post-radiation fibrosis, and many other diseases. The primary symptoms of ILD are nonspecific, such as non-productive cough and progressive breathlessness. These symptoms are seen in many other medical conditions such as asthma, heart failure, or chronic obstructive pulmonary disease (COPD). The lack of specificity of the presenting symptoms makes the identification of ILD challenging, particularly in individuals with known heart or lung disease. Early and accurate diagnosis of ILD is essential so that treatment options can be considered before extensive and permanent damage occurs, resulting in disabling breathlessness. While there is currently no proven, FDA-approved treatment for idiopathic pulmonary fibrosis, many forms of interstitial lung disease can be treated, if detected early in the disease process. Thus, having a low threshold for suspecting interstitial disease, and assessing a patient’s risk of developing pulmonary fibrosis by obtaining important historical information is critical to early diagnosis. Interstitial lung disease is usually evaluated and treated by pulmonologists. Primary care providers and other specialists, however, are often the first to see a patient and suspect a diagnosis of interstitial lung disease. Evaluation of a patient with interstitial lung disease requires a detailed history that includes information regarding occupational and recreational exposures, medical history, medication and drug use history, and a physical examination. Testing may include high resolution computed tomography scan of the chest, blood tests, pulmonary function tests, chest X-rays, bronchoscopy, and a lung biopsy. The interstitial lung disease evaluation MedicalTemplate has prompters for the occupational and recreation history, medical history, medication use that can cause ILD, drug use history, physical examination, and testing options. This assists physicians in efficiently documenting a thorough history. A sample of the Interstitial Lung Disease Evaluation MedicalTemplate can be downloaded from http://www.e-medtools.com/SAMPLE_ILD_Evaluation.pdf MedicalTemplates are created with Adobe PDF technology from Adobe Systems Incorporated (Nasdaq: ADBE), and have editable text fields and working checkboxes. Information can be typed in or pasted from other applications to fill out the template. Completed MedicalTemplates can be saved to a computer, USB drive, CD, DVD, or other storage device at a fraction of the cost of an electronic medical record. MedicalTemplates can be searched, reviewed, printed, or modified whenever needed without internet access or a connection to a remote computer. Data from a MedicalTemplate can be cut and pasted into another application. The Interstitial Lung Disease Evaluation MedicalTemplate costs $50 for an individual license and is sold by RegNow, the software industry’s premier e-commerce provider. The Interstitial Lung Disease Evaluation MedicalTemplate is available for immediate electronic delivery. RegNow accepts credit cards, checks, wire transfers, PayPal, and purchase orders. Volume discounts are available. The Interstitial Lung Disease Evaluation MedicalTemplate can be customized to meet the needs of any medical practice. More information regarding the Interstitial Lung Disease Evaluation MedicalTemplate can be found at http://www.e-medtools.com/ildeval.html Contact Information Robert Robinson
This email address is being protected from spam bots, you need Javascript enabled to view it
http://www.e-medtools.com/forms.html |
About the Press Release
MedicalTemplates have expanded to include an Interstitial Lung Disease evaluation. Interstitial lung disease is a diverse group of conditions that cause pulmonary fibroisis and breathlessness.
|
|